Advyzon Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
15,042
+3,116
+26% +$251K 0.09% 229
2026
Q1
$1.03M Buy
11,926
+2,537
+27% +$243K 0.09% 224
2025
Q4
$902K Buy
9,389
+3,524
+60% +$342K 0.1% 196
2025
Q3
$559K Buy
5,865
+1,060
+22% +$97.4K 0.1% 204
2025
Q2
$419K Buy
4,805
+292
+6% +$24.8K 0.09% 207
2025
Q1
$406K Buy
4,513
+16
+0.4% +$1.43K 0.14% 135
2024
Q4
$359K Buy
+4,497
New +$389K 0.14% 139

Other funds holding MDT

Advyzon Investment Management's MDT Position: Q2 2026 in Review

Advyzon Investment Management increased its Medtronic (MDT) stake by 26% in Q2 2026, buying an estimated $251K and bringing the position to 15,042 shares worth $1.18M. The position accounts for 0.09% of the portfolio, ranked #229.

Advyzon Investment Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Advyzon Investment Management held 15,042 shares of Medtronic worth $1.18M as of Q2 2026.
  • Advyzon Investment Management bought 3,116 Medtronic shares in Q2 2026, an estimated $251K.
  • Medtronic made up 0.09% of Advyzon Investment Management's portfolio in Q2 2026, its #229 holding.
  • Advyzon Investment Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.